Colgate-Palmolive’s stock slips on weaker-than-expected guidance despite Q4 profit beat
Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.
Colgate-Palmolive Q4: EPS Beat, Sales Miss, Cautious FY25 Forecast And More
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic sales rose by 4.3%, and non-GAAP EPS of $0.91 surpassed the consensus. The company expects flat FY25 sales.
Colgate-Palmolive: Q4 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Colgate-Palmolive Co. (CL) on Friday reported fourth-quarter net income of $739 million. The New York-based company said it had profit of 90 cents per share. Earnings, adjusted for non-recurring costs, came to 91 cents per share.
Colgate-Palmolive 4Q Sales Slip Lower; 2025 Sales Seen Roughly Flat
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected]
Colgate-Palmolive stock analysis: overvalued ahead of earnings
What is the outlook of the Colgate Palmolive stock price ahead of earnings? We explain whether it may drop soon
Colgate-Palmolive's lackluster guidance upstages solid Q4 results
The lackluster guidance upstaged an otherwise solid quarter for the company. For the reported quarter, Colgate ( NYSE: CL) earned an adjusted profit of $0.91, up 4.5% from a year ago and 2 cents better than expected.
Colgate-Palmolive’s stock slips despite Q4 profit beat and revenue ‘milestone’
Colgate-Palmolive Co. shares are down 0.7% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.
Colgate-Palmolive Co. Q4 Profit Increases, Beats Estimates
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the
Colgate-Palmolive (NYSE:CL) Misses Q4 Revenue Estimates
Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2024, with sales flat year on year at $4.94 billion. Its non-GAAP profit of $0.91 per share was 2.3% above analysts’ consensus estimates.
Colgate-Palmolive sees weaker annual sales on demand slowdown
Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales ...
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate-Palmolive Sees FY25 Earnings, Organic Sales Growth - Update
While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated its earnings, adjusted ...
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Would you like to be notified of the latest news and updates on the stock market?
Colgate-Palmolive sees weaker annual sales growth on demand slowdown
The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in ...
Analysts Offer Insights on Consumer Goods Companies: Colgate-Palmolive (CL) and Lamb Weston Holdings (LW)
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Colgate-Palmolive (CL – Research Report) ...
Colgate-Palmolive (NYSE:CL) Shares Sold by Geneos Wealth Management Inc.
Geneos Wealth Management Inc. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% during the ...
Reduce Colgate Palmolive India; target of Rs 2721: KR Choksey
KR Choksey recommended reduce rating on Colgate Palmolive India with a target price of Rs 2721 in its research report dated ...